Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice
The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.
Abstract
Spinal muscular atrophy (SMA) is the most common genetic disease leading to infant mortality. This neuromuscular disorder is caused by the loss or mutation of the telomeric copy of the 'survival of motor neuron' (Smn) gene, termed SMN1. Loss of SMN1 leads to reduced SMN protein levels, inducing degeneration of motor neurons (MN) and progressive muscle weakness and atrophy. To date, SMA remains incurable due to the lack of a method to deliver therapeutically active molecules to the spinal cord. Gene therapy, consisting of reintroducing SMN1 in MNs, is an attractive approach for SMA. Here we used postnatal day 1 systemic injection of self-complementary adeno-associated virus (scAAV9) vectors carrying a codon-optimized SMN1 sequence and a chimeric intron placed downstream of the strong phosphoglycerate kinase (PGK) promoter (SMNopti) to overexpress the human SMN protein in a mouse model of severe SMA. Survival analysis showed that this treatment rescued 100% of the mice, increasing life expectancy from 27 to over 340 days (median survival of 199 days) in mice that normally survive about 13 days. The systemic scAAV9 therapy mediated complete correction of motor function, prevented MN death and rescued the weight loss phenotype close to normal. This study reports the most efficient rescue of SMA mice to date after a single intravenous injection of an optimized SMN-encoding scAAV9, highlighting the considerable potential of this method for the treatment of human SMA.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Preclinical studies, delivering scAAV9-SMN to SMA pups, demonstrated positive effects on survival, growth, and neuromuscular transmission.11,12”
From Current clinical applications of in vivo gene therapy with AAVs (2021) · cites this paper as [12]
Citations
Cites
1 retracted
Foust, K. D., Wang, X., McGovern, V. L., Braun, L., Bevan, A. K., Haidet, A. M., Le, T. T., Morales, P. R., Rich, M. M., Burghes, A. H. M., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1610 · Cited by 688
RetractedIdentification and characterization of a spinal muscular atrophy-determining gene
Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichou, B., Cruaud, C., Millasseau, P., Zeviani, M., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90460-3 · Cited by 3,990 · cited 1×
“The gene responsible for the most common form of SMA was identified in 1995 and named ‘survival motor neuron’ (Smn) (2).”
BackgroundIntravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
Foust, K. D., Nurre, E., Montgomery, C. L., Hernandez, A., Chan, C. M., & Kaspar, B. K. (2009) · Nature Biotechnology · doi:10.1038/nbt.1515 · Cited by 1,456 · cited 1×
“An independent study similarly demonstrated the high potential of self-complementary AAV of serotype 9 (scAAV9) for neuronal transduction, albeit only in neonatal mice (9).”
Lambrechts, D., Storkebaum, E., Morimoto, M., Del-Favero, J., Desmet, F., Marklund, S. L., Wyns, S., Thijs, V., Andersson, J., van Marion, I., et al. (2003) · Nature Genetics · doi:10.1038/ng1211 · Cited by 860
Monani, U. R. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.3.333 · Cited by 729
Neuroblastoma × spinal cord (NSC) hybrid cell lines resemble developing motor neurons
Cashman, N. R., Durham, H. D., Blusztajn, J. K., Oda, K., Tabira, T., Shaw, I. T., Dahrouge, S., & Antel, J. P. (1992) · Developmental Dynamics · doi:10.1002/aja.1001940306 · Cited by 722
Introns increase transcriptional efficiency in transgenic mice.
Brinster, R. L., Allen, J. M., Behringer, R. R., Gelinas, R. E., & Palmiter, R. D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.3.836 · Cited by 722 · cited 1×
“Heterologous introns have been indeed reported to improve gene expression, by influencing transcriptional initiation or elongation (via enhancers or other cis-acting elements), by enhancing mRNA stability in the nucleus (via the process of mRNA splicing), or by facilitating opening of chromosomal domains (13,14) The P…”
BackgroundA mouse model for spinal muscular atrophy
Hsieh-Li, H. M., Chang, J.-G., Jong, Y.-J., Wu, M.-H., Wang, N. M., Tsai, C. H., & Li, H. (2000) · Nature Genetics · doi:10.1038/71709 · Cited by 702
Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model
Hua, Y., Sahashi, K., Hung, G., Rigo, F., Passini, M. A., Bennett, C. F., & Krainer, A. R. (2010) · Genes & Development · doi:10.1101/gad.1941310 · Cited by 664 · cited 1×
“Moreover, this pathological feature was observed from 3 to 4 weeks of age in the scAAV9-SMNopti treated severe SMA mice, similarly to what was recently described after antisense correction of SMN2 splicing in a mild SMA model (42).”
BackgroundHerzog, E., Bellenchi, G. C., Gras, C., Bernard, V., Ravassard, P., Bedet, C., Gasnier, B., Giros, B., & El Mestikawy, S. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-22-j0001.2001 · Cited by 625 · cited 1×
“ISHs were performed as previously described (50,51)) on 14 mm thick serial sections of cervical spinal cord.”
MethodSelf-citation
Cited by
Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
Mendell, J. R., Al-Zaidy, S., Shell, R., Arnold, W. D., Rodino-Klapac, L. R., Prior, T. W., Lowes, L., Alfano, L., Berry, K., Church, K., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1706198 · Cited by 2,381
Hinderer, C., Katz, N., Buza, E. L., Dyer, C., Goode, T., Bell, P., Richman, L. K., & Wilson, J. M. (2018) · Human Gene Therapy · doi:10.1089/hum.2018.015 · Cited by 814
Current clinical applications of in vivo gene therapy with AAVs
Mendell, J. R., Al-Zaidy, S. A., Rodino-Klapac, L. R., Goodspeed, K., Gray, S. J., Kay, C. N., Boye, S. L., Boye, S. E., George, L. A., Salabarria, S., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2020.12.007 · Cited by 743
“Preclinical studies, delivering scAAV9-SMN to SMA pups, demonstrated positive effects on survival, growth, and neuromuscular transmission.(11,12) Two key observations from these studies worth noting were both time of intervention and dose response effects on survival.”
BackgroundHua, Y., Sahashi, K., Rigo, F., Hung, G., Horev, G., Bennett, C. F., & Krainer, A. R. (2011) · Nature · doi:10.1038/nature10485 · Cited by 741
Kolb, S. J., & Kissel, J. T. (2015) · Neurologic Clinics · doi:10.1016/j.ncl.2015.07.004 · Cited by 603
Metadata
- Authors
- Dominguez, E., Marais, T., Chatauret, N., Benkhelifa-Ziyyat, S., Duque, S., Ravassard, P., Carcenac, R., Astord, S., de Moura, A. P., Voit, T., & Barkats, M.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Barkats, Martine
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-11-30
- Volume
- 20
- Issue
- 4
- Pages
- 681-693
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2119878613
- Cited by
- 298
- References
- 52
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 11 · 2023: 10 · 2022: 8 · 2021: 17 · 2020: 17 · 2019: 17 · 2018: 15 · 2017: 21 · 2016: 21 · 2015: 31 · 2014: 29 · 2013: 33 · 2012: 23
- FWCI
- 11.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- California Department of Transportation
- National Science Council
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Keywords
- spinal muscular atrophy, SMN1, gene therapy, codon optimization, intravenous delivery, motor neuron survival, phosphoglycerate kinase promoter, SMA mouse model
- MeSH terms
- Dependovirus, Animals, Disease Models, Animal, Female, Genetic Vectors, Humans, Motor Neurons, Muscular Atrophy, Spinal, Phenotype, Spinal Cord, Genetic Therapy, Survival Analysis, Treatment Outcome, Gene Transfer Techniques, Mice, Knockout, Mice, Survival of Motor Neuron 1 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice. https://app.cochat.ai/papers/10.1093/hmg/ddq514
- The paper
- Dominguez, E., Marais, T., Chatauret, N., Benkhelifa-Ziyyat, S., Duque, S., Ravassard, P., Carcenac, R., Astord, S., de Moura, A. P., Voit, T., & Barkats, M. (2011). Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddq514
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.